CELLSEARCH
Total Payments
$18,183
Transactions
16
Doctors
11
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $2,335 | 3 | 2 |
| 2019 | $964.85 | 11 | 7 |
| 2017 | $14,883 | 2 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $14,883 | 2 | 81.9% |
| Unspecified | $2,197 | 1 | 12.1% |
| Food and Beverage | $1,103 | 13 | 6.1% |
Payments by Type
General
$15,986
15 transactions
Research
$2,197
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ACT-MBC: A Prospective Observational Impact Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer | MENARINI SILICON BIOSYSTEMS, INC. | $2,197 | 0 |
Top Doctors Receiving Payments for CELLSEARCH
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology & Oncology | Rochester, MN | $11,118 | 1 |
| , MD | Gynecology | Houston, TX | $3,765 | 1 |
| Unknown | — | Rochester, MN | $2,197 | 1 |
| , MD | Medical Oncology | New York, NY | $330.62 | 3 |
| , M.D | Medical Oncology | Chicago, IL | $173.20 | 3 |
| , MD | Medical Oncology | Durham, NC | $131.67 | 1 |
| , M.D | Surgical Oncology | Houston, TX | $119.70 | 1 |
| , MD | Medical Oncology | The Bronx, NY | $114.70 | 1 |
| , MD | Internal Medicine | Ann Arbor, MI | $114.70 | 1 |
| , MD | Hematology & Oncology | Seattle, WA | $84.25 | 1 |
| , M.D | Therapeutic Radiology | Bolivar, MO | $18.54 | 1 |
| , M.D | Hematology & Oncology | Los Angeles, CA | $15.71 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $18,183
- Total Doctors 11
- Transactions 16
About CELLSEARCH
CELLSEARCH is a device associated with $18,183 in payments to 11 healthcare providers, recorded across 16 transactions in the CMS Open Payments database. The primary manufacturer is MENARINI SILICON BIOSYSTEMS, INC..
Payment data is available from 2017 to 2023. In 2023, $2,335 was paid across 3 transactions to 2 doctors.
The most common payment nature for CELLSEARCH is "Travel and Lodging" ($14,883, 81.9% of total).
CELLSEARCH is associated with 1 research study, including "ACT-MBC: A Prospective Observational Impact Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer" ($2,197).